ARCHIVES

Cancer Programs Close Amid Gridlock

This article is from The Cancer Letter archive.

Vol. 39 No. 37 | October 4, 2013

Download PDF Visit The Full Archive

Related Articles

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

NIEHS Uses Gene Chips To Evaluate Chemicals.

March 3, 2000

CMS Issues Coverage Decision For Provenge in Prostate Cancer

July 29, 2011

DeVita Says NCAB Subcommittee’s Recommendation For Reshaping Organ Site Program Is “Reasonable”

April 23, 1982

Home-Based Program Helps Older Cancer Survivors

May 29, 2009

ACS-Roosevelt Awards Go to 19 New Fellows

July 30, 1976